Viking Therapeutics (VKTX) News Today $31.70 +0.07 (+0.21%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Viking Therapeutics (NASDAQ:VKTX) Trading 0.5% Higher - Here's What HappenedViking Therapeutics (NASDAQ:VKTX) Trading Up 0.5% - Should You Buy?February 20 at 1:42 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading 3.3% Higher - Here's WhyViking Therapeutics (NASDAQ:VKTX) Trading 3.3% Higher - What's Next?February 19 at 6:42 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 7.6% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Trading 7.6% Higher - Still a Buy?February 19 at 2:37 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Down 2% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2% - Here's WhyFebruary 18 at 11:38 PM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Up 3.3% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Shares Up 3.3% - Here's WhyFebruary 17, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 3.4% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Trading Up 3.4% - Here's WhyFebruary 16, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Short Interest Up 18.5% in JanuaryViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) saw a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 23,930,000 shares, an increase of 18.5% from the January 15th total of 20,200,000 shares. Based on an average trading volume of 4,060,000 shares, the days-to-cover ratio is currently 5.9 days.February 15, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 1.3% - Here's What HappenedViking Therapeutics (NASDAQ:VKTX) Trading Down 1.3% - Should You Sell?February 15, 2025 | marketbeat.comH.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)February 14, 2025 | markets.businessinsider.comViking Therapeutics (NASDAQ:VKTX) Shares Down 1.2% - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.2% - Should You Sell?February 14, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 3.4% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Trading 3.4% Higher - Should You Buy?February 14, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Coverage Initiated by Analysts at ScotiabankScotiabank started coverage on shares of Viking Therapeutics in a report on Thursday. They set a "sector outperform" rating and a $102.00 target price for the company.February 14, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 1.3% - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.3% - Here's What HappenedFebruary 13, 2025 | marketbeat.comScotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform RecommendationFebruary 13, 2025 | msn.comViking Therapeutics (NASDAQ:VKTX) Sets New 1-Year Low - What's Next?Viking Therapeutics (NASDAQ:VKTX) Hits New 1-Year Low - Should You Sell?February 13, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Earns Sector Outperform Rating from Analysts at ScotiabankScotiabank started coverage on Viking Therapeutics in a report on Thursday. They set a "sector outperform" rating and a $102.00 price target for the company.February 13, 2025 | marketbeat.comScotiabank starts Viking Therapeutics at Outperform, sees attractive entry pointFebruary 13, 2025 | markets.businessinsider.comMirae Asset Global Investments Co. Ltd. Takes $528,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Mirae Asset Global Investments Co. Ltd. purchased a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 13,284 shares of the bioFebruary 13, 2025 | marketbeat.comViking Therapeutics initiated with an Outperform at ScotiabankFebruary 12, 2025 | markets.businessinsider.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.2% - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.2% - Should You Sell?February 12, 2025 | marketbeat.comFY2025 Earnings Forecast for VKTX Issued By Leerink PartnrsFebruary 12, 2025 | americanbankingnews.comWilliam Blair Has Bearish Estimate for VKTX Q1 EarningsFebruary 12, 2025 | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Trading Down 4.9% Following Analyst DowngradeFebruary 12, 2025 | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Trading Down 1.7% - Here's What HappenedViking Therapeutics (NASDAQ:VKTX) Trading Down 1.7% - Here's What HappenedFebruary 11, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Reaches New 52-Week Low - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Hits New 12-Month Low - Time to Sell?February 11, 2025 | marketbeat.comWhy Viking Therapeutics Inc. (VKTX) Went Down on MondayFebruary 11, 2025 | finance.yahoo.comResearch Analysts Offer Predictions for VKTX Q1 EarningsFebruary 11, 2025 | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Shares Down 4.9% Following Analyst DowngradeViking Therapeutics (NASDAQ:VKTX) Shares Down 4.9% Following Analyst DowngradeFebruary 11, 2025 | marketbeat.com2 Stocks to Buy With Less Than $40February 10, 2025 | fool.com3 No-Brainer Healthcare Stocks to Buy With $200 Right NowFebruary 10, 2025 | fool.comLeerink Partnrs Has Negative Outlook of VKTX FY2025 EarningsViking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Analysts at Leerink Partnrs reduced their FY2025 EPS estimates for shares of Viking Therapeutics in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the biotechFebruary 10, 2025 | marketbeat.comQ1 Earnings Forecast for VKTX Issued By HC WainwrightViking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a report issued on Thursday, February 6th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology companyFebruary 10, 2025 | marketbeat.comQ1 EPS Estimate for Viking Therapeutics Lowered by AnalystViking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Analysts at William Blair dropped their Q1 2025 EPS estimates for shares of Viking Therapeutics in a research report issued on Wednesday, February 5th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will earn ($0February 10, 2025 | marketbeat.comCitigroup Initiates Coverage of Viking Therapeutics (VKTX) with Neutral RecommendationFebruary 8, 2025 | msn.com2 Stocks That Could Soar Again in 2025February 8, 2025 | fool.comDown 65%, Is Viking Therapeutics Stock a Buy on the Dip?February 8, 2025 | fool.comMaxim Group Lowers Viking Therapeutics (NASDAQ:VKTX) Price Target to $70.00Maxim Group decreased their price target on Viking Therapeutics from $120.00 to $70.00 and set a "buy" rating on the stock in a research report on Friday.February 7, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Earns "Buy" Rating from B. RileyB. Riley reissued a "buy" rating and issued a $96.00 price objective (down previously from $109.00) on shares of Viking Therapeutics in a research note on Friday.February 7, 2025 | marketbeat.comViking Therapeutics initiated with a Neutral at CitiFebruary 7, 2025 | markets.businessinsider.comViking Therapeutics price target lowered to $70 from $120 at MaximFebruary 7, 2025 | markets.businessinsider.comCitigroup Begins Coverage on Viking Therapeutics (NASDAQ:VKTX)Citigroup assumed coverage on Viking Therapeutics in a report on Friday. They set a "neutral" rating and a $38.00 price target for the company.February 7, 2025 | marketbeat.comWhat is William Blair's Forecast for VKTX FY2027 Earnings?Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Stock analysts at William Blair issued their FY2027 EPS estimates for Viking Therapeutics in a note issued to investors on Wednesday, February 5th. William Blair analyst A. Hsieh forecasts that the biotechnology company will post earnings peFebruary 7, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for VKTX Q1 Earnings?Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Viking Therapeutics in a report released on Wednesday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the biotechnology company will earn (February 7, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), McKesson (MCK)February 6, 2025 | markets.businessinsider.comViking Therapeutics price target raised to $125 from $122 at Raymond JamesFebruary 6, 2025 | markets.businessinsider.comViking Therapeutics (NASDAQ:VKTX) Stock Price Expected to Rise, Raymond James Analyst SaysRaymond James lifted their price objective on shares of Viking Therapeutics from $122.00 to $125.00 and gave the stock a "strong-buy" rating in a research report on Thursday.February 6, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down Following Weak EarningsViking Therapeutics (NASDAQ:VKTX) Shares Gap Down on Disappointing EarningsFebruary 6, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $102.00 target price on shares of Viking Therapeutics in a report on Thursday.February 6, 2025 | marketbeat.comPiper Sandler Lowers Viking Therapeutics (NASDAQ:VKTX) Price Target to $71.00Piper Sandler dropped their target price on shares of Viking Therapeutics from $74.00 to $71.00 and set an "overweight" rating on the stock in a research report on Thursday.February 6, 2025 | marketbeat.comHas the Bubble Burst for Viking Therapeutics Stock?February 6, 2025 | fool.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.460.60▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼1116▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viatris News Today Moderna News Today Dr. Reddy's Laboratories News Today Vaxcyte News Today Sarepta Therapeutics News Today Qiagen News Today Ascendis Pharma A/S News Today Roivant Sciences News Today Revolution Medicines News Today Legend Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
